Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Brain Metastases
Clinical trial register · China

Brain Metastases Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Shanghai 4 Beijing 4 Guangzhou 4 Changsha 2 Shenzhen 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai4 Beijing4 Guangzhou4 Changsha2 Shenzhen1
All 13 locations
Target enrolment
to

Brain Metastases trials in China

20 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Nanfang Hospital, Southern Medical University
Phase 2
46
Guangzhou
2026-06-01
Recruiting
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
NCT07481786Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou
2026-03-20
Not yet open
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
NCT07365410Non-small Cell Lung Cancer (NSCLC), Brain Metastases, Furmonertinib, EGFR Mutation
Tianjin Medical University Cancer Institute and Hospital
Phase 2
60
Tianjin
2026-01
Recruiting
Henan Cancer Hospital
Phase 2
224
Zhengzhou
2025-08-30
Recruiting
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
NCT06793332Triple-Negative Breast Cancer (TNBC), Brain Metastases
Fudan University
Phase 2
39
Shanghai
2025-02-05
Recruiting
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
NCT06702826Non Small Cell Lung Cancer, Brain Metastases, Stereotactic Radiation, Immunotherapy
Rongrong Zhou
Phase 2
20
Changsha
2024-11-01
Recruiting
Essen Biotech
Phase 1/2
85
Beijing
2024-10-20
Active, closed
Li-kun Chen
Phase 2
70
Guangzhou
2024-09-04
Active, closed
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
NCT06282874Carcinoma, Non-Small-Cell Lung, Brain Metastases, Leptomeningeal Metastasis
Guangdong Association of Clinical Trials
Phase 4
41
Dongguan, Foshan, Guangzhou
2024-08-01
Recruiting
Fudan University
Phase 2
54
Shanghai
2024-07-01
Recruiting
The First People's Hospital of Lianyungang
Not applicable
46
Lianyungang
2024-07-01
Recruiting
Fudan University
Phase 1/2
56
Shanghai
2024-01-15
Recruiting
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
NCT06457906Small-cell Lung Cancer, Brain Metastases, SRS, Stereotactic Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
340
Beijing
2023-09-01
Recruiting
TYK Medicines, Inc
Phase 2
420
Beijing
2023-08-17
Active, closed
Fudan University
Phase 2
202
Shanghai
2023-08-10
Recruiting
Sun Yat-sen University
Phase 3
232
Guangdong
2023-03-15
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT05535413Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine, UDT1
Hunan Cancer Hospital
Phase 1/2
30
Changsha
2023-01-01
Active, closed
Yatian Liu
Not applicable
40
Nanjing
2021-01-01
Active, closed
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
NCT03753685Nonsmall Cell Lung Cancer, Brain Metastases
Fudan University
Phase 2
27
Shenzhen
2019-04-12
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/condition/brain-metastases

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Brain Metastases.

How many Brain Metastases trials are recruiting in China?

12 of the 20 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 5 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brain Metastases), 20 studies
PhaseStudiesRecruitingShare
Phase 210550%
Phase 1/23315%
Phase 33315%
Not applicable2110%
Observational105%
Phase 4105%

Most active sponsors

Lead sponsors with the most studies (Brain Metastases)
Lead sponsorStudiesRecruiting
Fudan University53
Sun Yat-sen University22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Essen Biotech11
Guangdong Association of Clinical Trials10
Henan Cancer Hospital11
Hunan Cancer Hospital11
Li-kun Chen10
Ming Yang10
Nanfang Hospital, Southern Medical University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.